Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7541)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Charrière B, Maulat C, Suc B, Muscari F. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol 2016; 8(21): 881-890 [PMID: 27478538 DOI: 10.4254/wjh.v8.i21.881] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i21/881.htm |
| Number | Citing Articles |
| 1 |
Cheon-Soo Park, Yong-Kyu Chung, Sung-Hwa Kang, Shin Hwang. Diagnostic predictability of hepatocellular carcinoma tumor markers in patients waiting for living donor liver transplantation. Annals of Liver Transplantation 2022; 2(1): 34 doi: 10.52604/alt.22.0012
|
| 2 |
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, Ayana. R. Kumar, Benjamin S. Meyer, Arun Valsan, Vinod Vijayakurup, Lekshmi R. Nath. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma. Molecular Biotechnology 2023; doi: 10.1007/s12033-023-00890-0
|
| 3 |
Aventinus Nörthen, Thomas Asendorf, Philip D. Walson, Michael Oellerich. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation. Clinical Biochemistry 2018; 52: 20 doi: 10.1016/j.clinbiochem.2017.10.011
|
| 4 |
Xiangyi Cao, Yulong Zhang, Qianqian Zhou, Sujing Sun, Minwei He, Xiaohui Wang, Ping Ma, Xiaoang Yang, Liping Lv, Linsheng Zhan. Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.794101
|
| 5 |
Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation. Progress in Transplantation 2018; 28(1): 63 doi: 10.1177/1526924817746686
|
| 6 |
Ryan Lamm, Peter J. Altshuler, Keyur Patel, Osama Shaheen, Angel Paulo Amante, Jesse Civan, Warren Maley, Adam Frank, Carlo Ramirez, Jaime Glorioso, Ashesh Shah, Hien Dang, Adam S. Bodzin. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis. Transplant International 2022; 35 doi: 10.3389/ti.2022.10175
|
| 7 |
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181423
|
| 8 |
Xinju Chen, Fangming Yang, Chuanlei Zhang, Xinting Wang, Changwei Yuan, Dandan Shi, Shuaishuai Zhu, Xiaotong Zhang, Xiaoqi Chen, Wenxia Zhao. BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Journal of Molecular Histology 2024; 55(2): 159 doi: 10.1007/s10735-023-10179-w
|
| 9 |
Jin-Lin Wu, Tung-Hung Su, Pei-Jer Chen, Yun-Ru Chen. Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-09713-9
|
| 10 |
Salih TOKMAK. Hepatocellular Carcinoma with Increased AFP Levels and Extrahepatic Manifestation after Liver Transplantation: A Case of Late-Onset Recurrence. Düzce Tıp Fakültesi Dergisi 2019; 21(3): 263 doi: 10.18678/dtfd.653558
|
| 11 |
Po-Shuan Huang, Yang-Hsiang Lin, Hsiang-Cheng Chi, Yi-Hsin Tseng, Cheng Yi Chen, Tzu-Kang Lin, Chau-Ting Yeh, Kwang-Huei Lin. Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer. Cells 2020; 9(4): 961 doi: 10.3390/cells9040961
|
| 12 |
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experience. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
|
| 13 |
Francesco Marasciulo, Irene Passerini, Anna Fichera, Federico Ferrari, Franco E. Odicino, Federico Prefumo. Hepatocellular carcinoma in pregnancy: A systematic review. Acta Obstetricia et Gynecologica Scandinavica 2024; 103(4): 653 doi: 10.1111/aogs.14640
|
| 14 |
Ahmet Gurakar, Michelle Ma, Jacqueline Garonzik-Wang, Amy Kim, Robert A. Anders, Kiyoko Oshima, Christos Georgiades, Merve Gurakar, Shane Ottmann, Andrew M. Cameron, Benjamin Philosophe, Behnam Saberi. Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas. Annals of Hepatology 2018; 17(6): 1052 doi: 10.5604/01.3001.0012.7206
|
| 15 |
Shiyong Gao, Jian Gang, Miao Yu, Guosong Xin, Huixin Tan. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08520-1
|
| 16 |
Astrid Herrero, Lucile Boivineau, Gianluca Cassese, Eric Assenat, Benjamin Riviere, Stéphanie Faure, José Ursic Bedoya, Fabrizio Panaro, Boris Guiu, Francis Navarro, Georges-Philippe Pageaux. Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma. Transplant International 2022; 35 doi: 10.3389/ti.2022.10412
|
| 17 |
Rachel Hogen, Mary Lo, Joseph DiNorcia, Lingyun Ji, Yuri Genyk, Linda Sher, Kiran Dhanireddy. More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma. Transplantation 2019; 103(4): 747 doi: 10.1097/TP.0000000000002248
|
| 18 |
Kang Yu, Jing Tang, Jie-Li Wu, Biao Li, Shi-Nan Wu, Meng-Yao Zhang, Qiu-Yu Li, Li-Juan Zhang, Yi-Cong Pan, Qian-Min Ge, Hui-Ye Shu, Yi Shao. Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125. World Journal of Diabetes 2021; 12(2): 158-169 doi: 10.4239/wjd.v12.i2.158
|
| 19 |
Kunpeng Tian, Yongling Ying, Jingjing Huang, Hao Wu, Chengyue Wei, Liang Li, Longjun Chen, Lichuan Wu. The expression, immune infiltration, prognosis, and experimental validation of OSBPL family genes in liver cancer. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10713-9
|
| 20 |
Justin Hartke, Matthew Johnson, Marwan Ghabril. The diagnosis and treatment of hepatocellular carcinoma. Seminars in Diagnostic Pathology 2017; 34(2): 153 doi: 10.1053/j.semdp.2016.12.011
|
| 21 |
Yan-Ping Li, Wen-Ze Wang, Xue-Qi Chen, Ling-Bo Li, Zhi-Yong Liang, Kun Ru, Jing-Nan Li. Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis. Chinese Medical Journal 2017; 130(22): 2686 doi: 10.4103/0366-6999.218016
|
| 22 |
Shuyi Xiao, Zhiwen Hu, Yan He, Hai Jin, Yuwen Yang, Liping Chen, Qiaoli Chen, Qiong Luo, Jianhua Liu. Enhancement Effect of Microbubble-Enhanced Ultrasound in Microwave Ablation in Rabbit VX2 Liver Tumors. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3050148
|